Integrin β3E726 Regulates the Switch Between Platelet Spreading and Clot Retraction by Interfering Gα13/RhoA Pathway

Area of Science:

• Hematology
• Cell Biology
• Molecular Biology

Background:

• Platelet shape changes, including spreading and clot retraction, are crucial for hemostasis.
• These processes are mediated by integrin outside-in signaling, but regulatory mechanisms remain unclear.
• Previous work identified impaired spreading in Chinese hamster ovary (CHO) cells with a β3 integrin E726Q mutation.

Purpose of the Study:

• To investigate the role of the β3 integrin E726Q mutation in platelet function using knock-in mice.
• To elucidate the mechanisms by which the E726 residue differentially affects platelet spreading and clot retraction.

Main Methods:

• Generation and analysis of knock-in mice expressing the β3^E726Q mutation.
• Assessment of platelet aggregation, P-selectin exposure, fibrinogen binding, and clot retraction.
• Evaluation of bleeding time and in vitro/in vivo thrombogenesis.
• Mechanistic studies on RhoA, Rac1, and Gα13 activity in platelets.

Main Results:

• β3^E726Q platelets showed impaired fibrinogen binding, reduced aggregation, and attenuated P-selectin exposure.
• Defective platelet spreading and accelerated clot retraction with increased clot density were observed in β3^E726Q platelets.
• β3^E726Q mice exhibited prolonged bleeding times and defective thrombogenesis.
• Enhanced RhoA and Rac1 activity, linked to reduced Gα13 binding to the β3 cytoplasmic tail, was found in β3^E726Q platelets.

Conclusions:

• The β3 integrin E726 residue is a novel regulatory site impacting platelet shape dynamics.
• The E726Q mutation alters the interaction between the β3 cytoplasmic tail and Gα13, affecting RhoA activity.
• This molecular switch mechanism differentiates platelet spreading from clot retraction, with implications for hemostasis.